These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7996039)

  • 1. The use of exogenous surfactant replacement therapy in newborns with non-respiratory distress syndrome conditions.
    Stewart DL
    J Ky Med Assoc; 1994 Oct; 92(10):406-10. PubMed ID: 7996039
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary surfactant: functions, abnormalities and therapeutic options.
    Frerking I; Günther A; Seeger W; Pison U
    Intensive Care Med; 2001 Nov; 27(11):1699-717. PubMed ID: 11810113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous surfactant therapy in newborns.
    Rodriguez RJ; Martin RJ
    Respir Care Clin N Am; 1999 Dec; 5(4):595-616. PubMed ID: 10565883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5 W's of surfactant for respiratory distress syndrome of the premature infant.
    Parmigiani S
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant replacement therapy in the neonate: beyond respiratory distress syndrome.
    Donn SM; Dalton J
    Respir Care; 2009 Sep; 54(9):1203-8. PubMed ID: 19712497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal chronic lung disease and exogenous surfactant therapy.
    Greenough A
    Eur J Pediatr; 1998 Jan; 157 Suppl 1():S16-8. PubMed ID: 9462901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
    Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
    Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded use of surfactant therapy in newborns.
    Lacaze-Masmonteil T
    Clin Perinatol; 2007 Mar; 34(1):179-89, ix. PubMed ID: 17394937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
    Ho NK
    Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary surfactant deficiencies].
    Escande B; Kuhn P; Rivera S; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1351-9. PubMed ID: 15519836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities of therapy of respiratory distress syndrome in premature infants using natural surfactant].
    Speer CP; Harms K; Herting E
    Krankenpfl J; 1990; 28(7-8):388-91. PubMed ID: 2381156
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of exogenous surfactant replacement therapy on lung function.
    Yüksel B; Greenough A
    Turk J Pediatr; 1993; 35(1):53-7. PubMed ID: 8236518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary surfactant deficiencies in extremely low birth weight premature infants].
    Rivera S; Gaugler C; Langlet C; Villega F; Astruc D; Escande B; Kuhn P; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1346-50. PubMed ID: 15519835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Other indications for surfactant].
    Proença Fernandes E; Carvalho C; Silva A; Ferreira P; Alegria A; Lopes L; Areias MA
    An Esp Pediatr; 2002 Jan; 56(1):45-8. PubMed ID: 11792244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylaxis and treatment of respiratory distress syndrome with different surfactants].
    Navas Serrano VM; Cuevas García MA; Vila Alvarez JA; Martínez Fernández V; Morcillo Sopena F; Valls I Soler A
    An Esp Pediatr; 2002 Jan; 56(1):40-4. PubMed ID: 11792243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug treatments of respiratory distress syndrome in premature infants].
    Saliba E; Laugier J
    Pediatrie; 1993; 48(12):864-71. PubMed ID: 8047397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous surfactant therapy: newer developments.
    Lacaze-Masmonteil T
    Semin Neonatol; 2003 Dec; 8(6):433-40. PubMed ID: 15001115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pulmonary surfactant system: physiology, pathologies associated with its alteration and exogenous administration as therapeutic and diagnostic agent].
    Calmanovici G; Boccio J; Lysionek A; Salgueiro M; Caro R; Hager A; de Paoli T; Zubillaga M
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(4):175-90. PubMed ID: 9914807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.